Company Comparison
DNA Script vs BioAnalytics Pro
Side-by-side comparison of two portfolio companies — sector, funding stage, investors, valuation, and more.
| Metric | DNA Script | BioAnalytics Pro |
|---|---|---|
| Sector | Biotech | Biotech |
| Headquarters | Paris, France | Cambridge |
| Founded | 2014 | — |
| Status | Active | Active |
| Last Funding Stage | Series B | Series A |
| Total Funding | $134M | $45M |
| Valuation | — | — |
What They Build
DNA Script
Biotechnology company developing enzymatic DNA synthesis technology to enable on-demand, decentralized production of synthetic DNA for research and therapeutics.
BioAnalytics Pro
Cambridge-based biotech company developing advanced analytics solutions for life sciences applications.
Sector Overlap
Both DNA Script and BioAnalytics Pro operate in Biotech.
Browse all Biotech companies →Websites
Sponsored
AArchstone
The operating system for private capital.
Archstone runs the back office for venture, PE, real estate, and credit funds — LP reporting, capital calls, portfolio tracking, and fund accounting, in one platform. Now in alpha.
LP portal & reportingCapital callsPortfolio tracking$297/moNo AUM fees
14-day free trial. No credit card required.